Delaware Emerging Markets A Load Waived  DEMAX.LW
  Morningstar Report
Overall Morningstar
Rating™
What is this?
As of 2009-10-31
Out of
Diversified Emerging Mkts Funds
Rating derived from a weighted average of the fund's 3, 5, 10-year rating which are based on risk-adjusted performance.
Morningstar®
Style Box™
What is this?
   Large
   Value
  
  
As of 2009-06-30
Day Change
$ -0.08
  
NAV (2009-11-20)
$ 12.92
  
YTD Return % (2009-11-20)
69.33%
  
Total Assets ($ mil)
724
View Data Definitions
  Performance    
Growth of $10,000 Fund: Delaware Emerging Markets A Load Waived
(from 1999-01-01 to 2009-10-31) Category: Diversified Emerging Mkts
Index: MSCI EAFE NDTR_D
Total Annualized Returns % 1yr, 3yr and 5yr Returns as of 2009-11-20
Inception date: 1996-06-10 10yr and Inception Returns as of 2009-10-31
YTD Returns as of 2009-11-20
YTD 1 Year 3 Year 5 Year 10 Year Since Inception
Fund 69.33 114.96 8.63 15.46 14.57 9.06
+/- Category 10.19 58.30 5.71 1.24 3.66 ---
+/- MSCI EAFE NDTR_D 39.72 62.28 13.38 11.20 --- ---
Standardized Annual Returns %   more on standardized returns
Quarter-End (as of 2009-09-30) 64.09 20.48 10.38 16.65 15.00 9.38
Month-End (as of 2009-10-31) 59.11 56.53 7.46 15.23 14.57 9.06
After Tax Returns % (as of 2009-09-30 )  
On Distribution --- 54.11 2.69 11.58 12.40 ---
On Distribution & Sale of Shares --- 38.06 4.95 12.11 12.17 ---
Morningstar Rating --- --- ---
# of compared funds covered (3 yrs : out of 260 funds), (5 yrs : out of 193 funds), (10 yrs : out of 118 funds). Ratings are based on risk-adjusted performance. The maximum initial sales fee is none, the maximum deferred sales fee is none, and the maximum redemption sales fee is none.
The performance quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate thus an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted herein.
  Portfolio Profile    
Sector Breakdown %
Information 25.75
Software 0.00
Hardware 5.65
Media 1.91
Telecommunications 18.19
Service 16.75
Healthcare 0.01
Consumer Services 2.07
Business Services 1.90
Financial Services 12.77
Manufacturing 57.50
Consumer Goods 9.80
Industrial Materials 18.83
Energy 20.10
Utilities 8.78
Asset Allocation
% of Net Assets
Cash 0.5
Stocks 97.3
Bonds 0.0
Other 2.1
Foreign Stocks 95.1
(as a % of Assets)
Data through 2009-06-30 Data through 2009-06-30
 
Holding Status
Total Number of Stock Holdings 127 Turnover % 37
Total Number of Bond Holdings 0 30 Day SEC Yield % 0.02
% of Assets in Top 10 Holdings 26.40 ending as of 2009-09-30
View Data Definitions
Top 10 Holdings Sector Country % of Net
Assets
Centrais Ele. Brasileira S.A. Eletrobras Brazil 4.61
Petroleo Brasileiro S.A. Brazil 4.24
Vale Brazil 2.92
Gazprom OAO (EDR) Russia 2.78
PetroChina Company, Ltd. China 2.05
Vodacom Grp (Proprietary) Ltd --- South Africa 2.05
Samsung Electronics South Korea 2.01
Samsung Electnc --- South Korea 1.92
Sasol, Ltd. South Africa 1.91
China Mobile Ltd. ADR Hong Kong 1.91
Data through 2009-06-30
  Other Information
Fund Inception: 1996-06-10
Portfolio Manager  (Start Date)
Liu-Er Chen  (2006-09-25)
Liu-Er Chen heads the firm’s global Emerging Markets team, and he is also the portfolio manager for the Delaware Healthcare Fund, which launched in October 2007. Prior to joining Delaware Investments in September 2006, he spent nearly 11 years at Evergreen Investment Management Company, where he most recently served as managing director and senior portfolio manager. He co-managed the Evergreen Emerging Markets Growth Fund from 1999 to 2001, and became the Fund’s sole manager in 2001. He also served as the sole manager of the Evergreen Health Care Fund since its inception in 1999. Chen began his career at Evergreen in 1995 as an analyst covering Asian and global healthcare stocks, before being promoted to portfolio manager in 1998. Prior to his career in asset management, Chen worked for three years in sales, marketing, and business development for major American and European pharmaceutical and medical device companies. He is licensed to practice medicine in China and has experience in medical research at both the Chinese Academy of Sciences and Cornell Medical School. He holds an MBA with a concentration in management from Columbia Business School.
Sales Charge %
(taken from prospectus dated 2009-09-09)
Front: None
Deferred: None
Expense Ratio % 1.97
based on net assets
(taken from annual report dated 2007-11-30)
Correspondence Information
One Commerce Square
2005 Market Street
Philadelphia,  PA  19103
Telephone:
800-523-1918
215-255-1241
Data on this page does not include the fund's short positions (if any).
Show Data Definitions

© Copyright 2009 Morningstar, Inc. All rights reserved. Morningstar, the Morningstar logo, Morningstar.com, Morningstar Tools are either trademark or service marks of Morningstar, Inc.
Past performance is no guarantee of future results.
Returns will vary and shares may be worth more or less than their original cost when sold.